Literature DB >> 21927994

Relation between (99m)Tc-tetrofosmin thyroid scintigraphy and mitogen-activated protein kinase in papillary thyroid cancer patients.

Kenkichi Baba1, Masatoshi Ishibashi, Hayato Kaida, Teruhiko Fujii, Yuji Hiromatsu, Akihiko Kawahara, Masayoshi Kage, Naofumi Hayabuchi.   

Abstract

PURPOSE: The aim of this study was to investigate the relation between (99m)Tc-tetrofosmin uptake and extracellular signal-regulated kinase mitogen-activated protein kinase (ERK MAPK) expression in papillary thyroid cancer patients.
MATERIALS AND METHODS: Our study population consisted of 14 patients. The histopathological findings for all patients were confirmed by surgery. Patients were administ 740 MBq of (99m)Tc-tetrofosmin. The tumor/background (T/B) ratios in regions of interest (ROIs) were measured at 10 min, 1 h, and 3 h to determine the uptake by papillary cancer. Immunohistopathological staining was performed, and the expression of phospho-ERK MAPK in papillary cancer was investigated. The relation between the expression of phospho-ERK MAPK and the T/B ratio was examined using the Mann-Whitney U-test.
RESULTS: (99m)Tc-tetrofosmin uptake was positive in all patients. There was a statistically significant relation between the T/B ratio (at 3 h) and the expression of phospho-ERK MAPK but not with the T/B ratio at 10 min or 1 h: T/B ratio at 10 min (P = 0.32), at 1 h (P = 0.62), and at 3 h (P = 0.0072).
CONCLUSION: Our results suggest that the relation between (99m)Tc-tetrofosmin uptake (3 h T/B ratio) may lead us to assume cell proliferation of papillary cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21927994     DOI: 10.1007/s11604-011-0592-8

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  26 in total

Review 1.  Single-photon agents for tumor imaging: 201Tl, 99mTc-MIBI, and 99mTc-tetrofosmin.

Authors:  Mitsutaka Fukumoto
Journal:  Ann Nucl Med       Date:  2004-04       Impact factor: 2.668

2.  BRAF(V600E) mutation influences hypoxia-inducible factor-1alpha expression levels in papillary thyroid cancer.

Authors:  Monica Zerilli; Giovanni Zito; Anna Martorana; Maria Pitrone; Daniela Cabibi; Francesco Cappello; Carla Giordano; Vito Rodolico
Journal:  Mod Pathol       Date:  2010-05-14       Impact factor: 7.842

3.  Transformation of mammalian cells by constitutively active MAP kinase kinase.

Authors:  S J Mansour; W T Matten; A S Hermann; J M Candia; S Rong; K Fukasawa; G F Vande Woude; N G Ahn
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

4.  Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells.

Authors:  Matthew D Ringel; Elena Hardy; Victor J Bernet; Henry B Burch; Frank Schuppert; Kenneth D Burman; Motoyasu Saji
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

5.  Brain tumor imaging with 99mTc-tetrofosmin: comparison with 201Tl, 99mTc-MIBI, and 18F-fluorodeoxyglucose.

Authors:  J Y Choi; S E Kim; H J Shin; B T Kim; J H Kim
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

6.  Comparison of the expression of P-glycoprotein, Ki-67, and P-53 to technetium-99m tetrofosmin mammoscintigraphic findings.

Authors:  Tse-Jia Liu; Shih-Chuan Tsai; Yung-Jen Ho; Shung-Shung Sun; Chia-Hung Kao
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

7.  Differentiated thyroid carcinoma: the new UICC 6th edition TNM classification system in a retrospective analysis of 169 patients.

Authors:  Natascha Döbert; Christian Menzel; Sabine Oeschger; Frank Grünwald
Journal:  Thyroid       Date:  2004-01       Impact factor: 6.568

8.  BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.

Authors:  Paula Soares; Vítor Trovisco; Ana Sofia Rocha; Jorge Lima; Patrícia Castro; Ana Preto; Valdemar Máximo; Tiago Botelho; Raquel Seruca; Manuel Sobrinho-Simões
Journal:  Oncogene       Date:  2003-07-17       Impact factor: 9.867

Review 9.  Cost-effectiveness of 99mTc-sestamibi in predicting response to chemotherapy in patients with lung cancer: systematic review and meta-analysis.

Authors:  Hosahalli K Mohan; Kenneth A Miles
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

10.  Technetium-99m tetrofosmin single photon emission computed tomography to detect metastatic papillary thyroid carcinoma in patients with elevated human serum thyroglobulin levels but negative I-131 whole body scan.

Authors:  H-S Wu; F-Y Liu; W-S Huang; Y-C Liu; C-T Chang; C-H Kao
Journal:  Clin Radiol       Date:  2003-10       Impact factor: 2.350

View more
  1 in total

1.  Patterns of FOXE1 expression in papillary thyroid carcinoma by immunohistochemistry.

Authors:  Andrey Bychkov; Vladimir Saenko; Masahiro Nakashima; Norisato Mitsutake; Tatiana Rogounovitch; Alyaksandr Nikitski; Florence Orim; Shunichi Yamashita
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.